Ha habido 50 transacciones internas recientes registradas para Collegium Pharmaceutical, Inc. (COLL), incluyendo 12 compras y 35 ventas. El total de compras internas fue valorado en RSU Award y el total de ventas internas en $13.5M.
Internos destacados con actividad reciente incluyen Dieter David, Dreyer Scott, Karnani Vikram. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — COLL
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-18 |
Dieter David |
EVP & General Counsel |
Venta Informativa |
13,976 |
$34.92 |
$488.1K |
77,071 |
| 2026-03-17 |
Dieter David |
EVP & General Counsel |
Retención Fiscal de RSU |
8,840 |
$35.72 |
$315.76K |
68,231 |
| 2026-03-03 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
3,559 |
$40.99 |
$145.88K |
71,770 |
| 2026-02-10 |
Karnani Vikram |
President and CEO |
Concesión de RSU |
79,264 |
- |
- |
176,629 |
| 2026-02-10 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Retención Fiscal de RSU |
21,615 |
$46.75 |
$1.01M |
121,746 |
| 2026-02-10 |
Smith Thomas B |
EVP and Chief Medical Officer |
Concesión de RSU |
14,268 |
- |
- |
85,312 |
| 2026-02-10 |
Tupper Colleen |
EVP & Chief Financial Officer |
Retención Fiscal de RSU |
26,679 |
$46.75 |
$1.25M |
147,282 |
| 2026-02-10 |
Dieter David |
EVP & General Counsel |
Concesión de RSU |
22,194 |
- |
- |
91,047 |
| 2025-12-08 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Ejercicio de Opciones (Venta) |
17,600 |
$15.90 |
$279.84K |
- |
| 2025-12-05 |
Balice-gordon Rita J. |
Director |
Venta Informativa |
3,650 |
$47.03 |
$171.67K |
52,629 |
| 2025-11-12 |
Fallon John A. |
Director |
Ejercicio de Opciones (Venta) |
19,853 |
$9.33 |
$185.23K |
- |
| 2025-11-12 |
Karnani Vikram |
President and CEO |
Retención Fiscal de RSU |
8,983 |
$47.35 |
$425.35K |
96,989 |
| 2025-11-06 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
4,858 |
$41.28 |
$200.52K |
126,667 |
| 2025-08-29 |
Smith Thomas B |
EVP and Chief Medical Officer |
Venta Informativa |
17,478 |
$38.42 |
$671.58K |
70,264 |
| 2025-08-18 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Ejercicio de Opciones (Venta) |
16,389 |
$21.34 |
$349.74K |
- |
| 2025-08-15 |
Santini Gino |
Director |
Ejercicio de Opciones (Venta) |
15,000 |
$13.45 |
$201.75K |
- |
| 2025-08-13 |
Rubric Capital Management Lp |
10 Percent Owner |
Venta Informativa |
25,000 |
$37.85 |
$946.25K |
3,132,743 |
| 2025-08-13 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Ejercicio de Opciones (Venta) |
4,861 |
$21.34 |
$103.73K |
16,389 |
| 2025-08-08 |
Freund John Gordon |
Director |
Venta Informativa |
11,659 |
$34.36 |
$400.64K |
23,129 |
| 2025-08-07 |
Rubric Capital Management Lp |
10 Percent Owner |
Desconocido |
- |
- |
- |
3,157,743 |
| 2025-06-09 |
Freund John Gordon |
Director |
Ejercicio de Opciones (Venta) |
15,000 |
$13.45 |
$201.75K |
- |
| 2025-05-15 |
Bohlin Garen G |
Director |
Concesión de RSU |
9,791 |
- |
- |
62,259 |
| 2025-05-15 |
Santini Gino |
Director |
Concesión de RSU |
9,791 |
- |
- |
85,447 |
| 2025-05-15 |
Freund John Gordon |
Director |
Concesión de RSU |
9,791 |
- |
- |
62,259 |
| 2025-05-15 |
Lurker Nancy |
Director |
Concesión de RSU |
9,791 |
- |
- |
22,517 |
| 2025-05-15 |
Fallon John A. |
Director |
Concesión de RSU |
9,791 |
- |
- |
64,634 |
| 2025-05-15 |
Paya Carlos V |
Director |
Desconocido |
- |
- |
- |
- |
| 2025-05-15 |
Paya Carlos V |
Director |
Concesión de RSU |
19,582 |
- |
- |
19,582 |
| 2025-05-15 |
Balice-gordon Rita J. |
Director |
Concesión de RSU |
9,791 |
- |
- |
56,279 |
| 2025-03-21 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
18,881 |
$30.03 |
$566.98K |
103,613 |
| 2025-03-21 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
6,396 |
$30.03 |
$192.07K |
156,667 |
| 2025-03-20 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
1,927 |
$30.00 |
$57.81K |
122,494 |
| 2025-03-20 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
1,206 |
$30.00 |
$36.18K |
163,063 |
| 2025-03-17 |
Dieter David |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-17 |
Dieter David |
EVP & General Counsel |
Concesión de RSU |
68,449 |
- |
- |
68,449 |
| 2025-03-14 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
2,255 |
$30.00 |
$67.66K |
124,421 |
| 2025-03-14 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
977 |
$30.00 |
$29.31K |
164,269 |
| 2025-03-11 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
10,445 |
$30.01 |
$313.41K |
165,246 |
| 2025-03-11 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
15,387 |
$30.00 |
$461.67K |
126,676 |
| 2025-03-07 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
2,348 |
$30.00 |
$70.45K |
142,063 |
| 2025-03-07 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
1,504 |
$30.00 |
$45.12K |
175,691 |
| 2025-03-06 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Venta Informativa |
26,067 |
$28.50 |
$742.95K |
108,137 |
| 2025-03-06 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
3,295 |
$30.00 |
$98.85K |
144,411 |
| 2025-03-06 |
Tupper Colleen |
EVP & Chief Financial Officer |
Venta Informativa |
1,949 |
$30.00 |
$58.47K |
177,195 |
| 2025-03-06 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Venta Informativa |
15,387 |
$30.00 |
$461.67K |
126,676 |
| 2025-03-05 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Venta Informativa |
20,000 |
$28.03 |
$560.53K |
134,204 |
| 2025-03-04 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Ejercicio de Opciones (Venta) |
40,000 |
$24.03 |
$961.2K |
- |
| 2025-02-10 |
Heffernan Michael Thomas |
Director |
Concesión de RSU |
4,820 |
- |
- |
50,328 |
| 2025-02-10 |
Kuhlmann Shirley R. |
EVP and General Counsel |
Retención Fiscal de RSU |
25,149 |
$30.52 |
$767.55K |
154,204 |
| 2025-02-10 |
Dreyer Scott |
EVP & Chief Commercial Officer |
Retención Fiscal de RSU |
21,670 |
$30.52 |
$661.37K |
147,706 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
